Table 4: Clinical symptoms and associated co-morbidities relative to tumor size.
|
Clinical manifestations |
Group A (n = 26) [< 4 cm] |
Group B (n = 39) [4-8 cm] |
Group C (n = 14) [> 8 cm] |
|
Headache |
3 (11.5%) |
7 (15.5%) |
3 (21.4%) |
|
Palpitation |
6 (23%) |
12 (26.7%) |
4 (28.6%) |
|
Sweating |
4 (15.4%) |
3 (6.7%) |
2 (14.3%) |
|
Dizziness |
0 |
1 (2.2%) |
1 (7.1%) |
|
Nausea |
0 |
3 (6.7%) |
1 (7.1%) |
|
Blurred of vision |
1 (3.8%) |
1 (2.2%) |
0 |
|
Hypertension |
15 (57.7%) |
32 (71.1%) |
12 (85.7%) |
|
Congestive Heart Failure |
0 |
2 (4.4%) |
0 |
|
NIDDM |
2 (7.7%) |
1 (2.2%) |
1 (7.1%) |
|
IDDM |
0 |
1 (2.2%) |
0 |
|
DMII |
1 (3.8%) |
3 (6.7%) |
3 (21.4%) |
NIDDM: Non-insulin Dependent Diabetes Mellitus; IDDM: Insulin Dependent Diabetes Mellitus; DMII: Diabetes Mellitus Type 2. Values expressed as means and percentage of the total.